Reading this on a mobile device? Try our optimized mobile version here:

May 22, 2013
SCAI SmartBrief
News for Invasive/Interventional Cardiologists
Sign up|Forward|Archive|Advertise

SCAI SmartBrief Special Report:
A look back at the SCAI 2013 Scientific Sessions
The SCAI 2013 Scientific Sessions brought together approximately 1,500 interventional cardiologists and cath lab colleagues for discussion of clinical advances and new developments -- including opportunities for quality improvement -- during this exciting time in health care. This special report from SCAI SmartBrief hits many of the highlights, and you can access nearly every presentation with SCAI 2013 On Demand.
Late-Breaking Clinical Trials 
Cardiovascular Health, Risk and Treatment 
  • Study finds more congenital heart defects repaired
    Over a decade, atrial septal defect and patent foramen ovale closures increased from a rate of 0.57 to 2.67 per 1 million people, while mean hospital stays fell from 5.82 to 3.24 days, according to a study presented at the SCAI 2013 Scientific Sessions. The study also identified factors linked to more successful outcomes including performing a closure at least 15 times annually. MedPage Today (free registration) (5/9) LinkedInFacebookTwitterEmail this Story
  • Other News
Cardiology in Practice 
  • Strategies for putting quality first
    A session at the SCAI 2013 Scientific Sessions that delved into quality and patient safety highlighted tools including registries, accreditation evaluations and the SCAI Quality Improvement Toolkit. SCAI Past President Dr. J. Jeffrey Marshall emphasized another important metric in addition to hard clinical outcomes: "Sometimes quality of life is more important than quality," he said in the concluding talk. The American Journal of Managed Care online (5/8) LinkedInFacebookTwitterEmail this Story
  • Other News
The President's Corner 
  • SCAI's 36th president sets stage for a year focused on quality
    SCAI President Dr. Ted Bass
    SCAI wrapped up its annual conference with a Town Hall meeting led by newly inducted President Dr. Ted Bass, who set the stage for the coming year with a continued focus on quality and special attention to the individual physician. "I look forward to continuing the momentum SCAI has already built around quality care in interventional cardiology and taking it one step further by working with each member to ensure a personal commitment to safe, quality cardiovascular care. SCAI's focus has been on improving quality one cath lab at a time. Now we will expand to improving quality one interventional cardiologist at a time." LinkedInFacebookTwitterEmail this Story

The Last Word From SCAI 
  • It's a wrap! SCAI 2013 is all wrapped up in one easy-to-access location
    For nearly four days, SCAI 2013 attendees had unlimited access to the Best of the Best in invasive and interventional cardiovascular education, from the new Quality Improvement educational track to the always-popular case-based sessions in the congenital, coronary, peripheral and structural tracks. Whether you missed a keynote or a key session, or you're eager for a recap of the whole meeting, we have SCAI 2013 all wrapped for easy access. Click here for research highlights, CME info, access to SCAI 2013 On Demand and much more. LinkedInFacebookTwitterEmail this Story
  • Acknowledgments for support
    SCAI gratefully acknowledges the following companies for their generous support of the SCAI 2013 Scientific Sessions through educational grants while taking sole responsibility for all content developed and disseminated through this event.
    • PLATINUM: Abbott Vascular; Boston Scientific
    • SILVER: AstraZeneca; Medtronic; The Medicines Company
    • BRONZE: Abiomed Inc.; Cook Medical; Cordis, a Johnson & Johnson company; Covidien; Gilead Sciences; St. Jude Medical; Terumo Interventional Systems

    SCAI also appreciates the educational grant support provided by Atrium Medical.

    SCAI thanks the following for their generous support of the SCAI 2013 Interventional Fellows Complex Coronary Complications (C3) Summit: Abbott Vascular; Boston Scientific; Cordis, a Johnson & Johnson company; Medtronic; St. Jude Medical; The Medicines Company.

    LinkedInFacebookTwitterEmail this Story

Product announcements appearing in SmartBrief are paid advertisements and do not reflect actual SCAI endorsements. The news reported in SmartBrief does not necessarily reflect the official position of SCAI.

The news summaries appearing in SCAI SmartBrief are based on original information from news organizations and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. SCAI is not responsible for the content of sites external to SCAI, nor do reports in SCAI SmartBrief constitute the official opinion of SCAI.
The SCAI SmartBrief news roundup is provided as a timely update for SCAI members and other healthcare professionals. Links to articles are provided for readers' convenience and may be of use in discussions with patients or colleagues. Questions and comments about SCAI SmartBrief may be directed to SmartBrief at
Subscriber Tools
Print friendly format  | Web version  | Search past news  | Archive  | Privacy policy

Account Director: Aaron Kern (202) 407-7866
 Recent SCAI SmartBrief Issues:   Lead Editor: Melissa Turner
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2013 SmartBrief, Inc.® Legal Information